These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30722673)

  • 1. Treatment-resistant depressive disorders: The when, how and what of augmentation therapy.
    Bassett D; Parker G; Hamilton A; Morris G; Baune BT; Boyce P; Hopwood M; Mulder R; Porter R; Singh A; Outhred T; Mannie Z; Das P; Malhi GS
    Aust N Z J Psychiatry; 2019 Mar; 53(3):187-189. PubMed ID: 30722673
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamotrigine augmentation therapy in a case with treatment-resistant unipolar depression that showed insufficient response to electroconvulsive therapy.
    Mihara K; Nakamura A; Nemoto K; Nagai G; Kagawa S; Suzuki T; Kondo T
    Psychiatry Clin Neurosci; 2016 Feb; 70(2):126. PubMed ID: 26661501
    [No Abstract]   [Full Text] [Related]  

  • 3. Electroconvulsive therapy in a patient with drug-resistant depression and thyroid hormone imbalance.
    Oglodek E; Szota A; Araszkiewicz A
    Aust N Z J Psychiatry; 2014 Jan; 48(1):96-7. PubMed ID: 23814070
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpersonal psychotherapy as add-on for treatment-resistant depression: A pragmatic randomized controlled trial.
    Souza LH; Salum GA; Mosqueiro BP; Caldieraro MA; Guerra TA; Fleck MP
    J Affect Disord; 2016 Mar; 193():373-80. PubMed ID: 26799332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic depression--epidemiological data and therapeutic options].
    Schüle C
    Fortschr Neurol Psychiatr; 2014 Mar; 82(3):155-71; quiz 172-3. PubMed ID: 24615587
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment-resistant depression in adolescents: review and updates on clinical management.
    Maalouf FT; Atwi M; Brent DA
    Depress Anxiety; 2011 Nov; 28(11):946-54. PubMed ID: 21898710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium augmentation as an alternative to maintenance electroconvulsive therapy for recurrent major depressive disorder in older adults.
    Wysoczanski D; Cherry S; Spivak V; Lie D; Brisbane DS
    Australas Psychiatry; 2017 Feb; 25(1):84. PubMed ID: 28145138
    [No Abstract]   [Full Text] [Related]  

  • 8. Support, patience, and expectancy: therapeutic options alongside intensified treatments for depression?
    Patten SB
    Can J Psychiatry; 2014 Jul; 59(7):347-8. PubMed ID: 25007418
    [No Abstract]   [Full Text] [Related]  

  • 9. Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.
    Bartova L; Weidenauer A; Dold M; Naderi-Heiden A; Kasper S; Willeit M; Praschak-Rieder N
    J ECT; 2017 Sep; 33(3):e31-e32. PubMed ID: 28520578
    [No Abstract]   [Full Text] [Related]  

  • 10. [The care standard 'Depressive disorders'].
    Spijker J; Meeuwissen JAC; Aalbers S; van Avendonk M; van Bon M; Huson A; van der Lande J; Oudijk M; Bockting C; Ruhé HG
    Tijdschr Psychiatr; 2019; 61(2):112-120. PubMed ID: 30793272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some augmentation strategies improve outcome but increase discontinuation in adults with treatment-resistant depression.
    Andrade C
    Evid Based Ment Health; 2016 May; 19(2):e7. PubMed ID: 27208385
    [No Abstract]   [Full Text] [Related]  

  • 12. Relapse prevention after index electroconvulsive therapy in treatment-resistant depression.
    Youssef NA; McCall WV
    Ann Clin Psychiatry; 2014 Nov; 26(4):288-96. PubMed ID: 25401716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasticity-augmented psychotherapy for refractory depressive and anxiety disorders.
    Choi KY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():134-47. PubMed ID: 27072378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mistreatment of major depressive disorder.
    Paris J
    Can J Psychiatry; 2014 Mar; 59(3):148-51. PubMed ID: 24881163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis.
    Strawbridge R; Carter B; Marwood L; Bandelow B; Tsapekos D; Nikolova VL; Taylor R; Mantingh T; de Angel V; Patrick F; Cleare AJ; Young AH
    Br J Psychiatry; 2019 Jan; 214(1):42-51. PubMed ID: 30457075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 17. Aripiprazole Augmentation in Older Persons with Treatment-Resistant Depression.
    Lewis G; Lewis G
    N Engl J Med; 2023 Mar; 388(12):1137-1138. PubMed ID: 36867178
    [No Abstract]   [Full Text] [Related]  

  • 18. Using adjunctive treatments when first-line antidepressants fail.
    Thase ME
    J Clin Psychiatry; 2012 Jan; 73(1):e01. PubMed ID: 22316580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment resistant depression in elderly.
    Wang SC; Yokoyama JS; Tzeng NS; Tsai CF; Liu MN
    Prog Brain Res; 2023; 281():25-53. PubMed ID: 37806715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Ketamine as a Treatment Option in Patients With Treatment Resistant Depression and Comorbid Arterial Hypertension.
    Silberbauer LR; Bartova L; Papageorgiou K; Lanzenberger R; Kasper S; Winkler D
    J Clin Psychopharmacol; 2020; 40(4):418-420. PubMed ID: 32639297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.